BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

845 related articles for article (PubMed ID: 9579845)

  • 1. Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma.
    Scheithauer W; Kornek GV; Marczell A; Karner J; Salem G; Greiner R; Burger D; Stöger F; Ritschel J; Kovats E; Vischer HM; Schneeweiss B; Depisch D
    Br J Cancer; 1998 Apr; 77(8):1349-54. PubMed ID: 9579845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorouracil plus leucovorin as effective adjuvant chemotherapy in curatively resected stage III colon cancer: results of the trial adjCCA-01.
    Porschen R; Bermann A; Löffler T; Haack G; Rettig K; Anger Y; Strohmeyer G;
    J Clin Oncol; 2001 Mar; 19(6):1787-94. PubMed ID: 11251010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined intraperitoneal plus intravenous chemotherapy after curative resection for colonic adenocarcinoma.
    Scheithauer W; Kornek G; Rosen H; Sebesta C; Marcell A; Kwasny W; Karall M; Depisch D
    Eur J Cancer; 1995 Nov; 31A(12):1981-6. PubMed ID: 8562152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial.
    Arkenau HT; Bermann A; Rettig K; Strohmeyer G; Porschen R;
    Ann Oncol; 2003 Mar; 14(3):395-9. PubMed ID: 12598344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion.
    Arkenau HT; Rettig K; Porschen R
    Int J Colorectal Dis; 2005 May; 20(3):258-61. PubMed ID: 15549327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer.
    Kelsen DP; Saltz L; Cohen AM; Yao TJ; Enker W; Tong W; Tao Y; Bertino JR
    Cancer; 1994 Oct; 74(8):2224-33. PubMed ID: 7922973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.
    O'Connell MJ; Laurie JA; Kahn M; Fitzgibbons RJ; Erlichman C; Shepherd L; Moertel CG; Kocha WI; Pazdur R; Wieand HS; Rubin J; Vukov AM; Donohue JH; Krook JE; Figueredo A
    J Clin Oncol; 1998 Jan; 16(1):295-300. PubMed ID: 9440756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity and effects of adjuvant therapy in colon cancer: results of the German prospective, controlled randomized multicenter trial FOGT-1.
    Staib L; Link KH; Beger HG;
    J Gastrointest Surg; 2001; 5(3):275-81. PubMed ID: 11419451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The addition of low-dose leucovorin to the combination of 5-fluorouracil- levamisole does not improve survival in the adjuvant treatment of Dukes' C colon cancer. IKN Colon Trial Group.
    Bleeker WA; Mulder NH; Hermans J; Otter R; Plukker JT
    Ann Oncol; 2000 May; 11(5):547-52. PubMed ID: 10907947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.
    Haller DG; Catalano PJ; Macdonald JS; O'Rourke MA; Frontiera MS; Jackson DV; Mayer RJ
    J Clin Oncol; 2005 Dec; 23(34):8671-8. PubMed ID: 16314627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
    Poplin EA; Benedetti JK; Estes NC; Haller DG; Mayer RJ; Goldberg RM; Weiss GR; Rivkin SE; Macdonald JS
    J Clin Oncol; 2005 Mar; 23(9):1819-25. PubMed ID: 15774775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leucovorin and fluorouracil vs levamisole and fluorouracil as adjuvant chemotherapy in rectal cancer.
    Tsavaris N; Gennatas K; Kosmas C; Skopelitis HM; Gouveris P; Dimitrakopoulos A; Zacharakis M; Kouraklis G; Vasiliou J; Felekouras E; Voros D; Zografos G; Balafouta M; Paraskevaidis M; Safioleas M; Fotiadis K; Papastratis G; Karatzas G; Papalambros E
    Oncol Rep; 2004 Oct; 12(4):927-32. PubMed ID: 15375524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National Surgical Adjuvant Breast and Bowel Project trials in colon cancer.
    Wolmark N; Colangelo L; Wieand S
    Semin Oncol; 2001 Feb; 28(1 Suppl 1):9-13. PubMed ID: 11273592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant sequential methotrexate --> 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer.
    Sobrero A; Frassineti G; Falcone A; Dogliotti L; Rosso R; Di Costanzo F; Bruzzi P;
    Br J Cancer; 2005 Jan; 92(1):24-9. PubMed ID: 15611795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04.
    Wolmark N; Rockette H; Mamounas E; Jones J; Wieand S; Wickerham DL; Bear HD; Atkins JN; Dimitrov NV; Glass AG; Fisher ER; Fisher B
    J Clin Oncol; 1999 Nov; 17(11):3553-9. PubMed ID: 10550154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114.
    Tepper JE; O'Connell MJ; Petroni GR; Hollis D; Cooke E; Benson AB; Cummings B; Gunderson LL; Macdonald JS; Martenson JA
    J Clin Oncol; 1997 May; 15(5):2030-9. PubMed ID: 9164215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. North Central Cancer Treatment Group--Mayo Clinic trials in colon cancer.
    O'Connell MJ
    Semin Oncol; 2001 Feb; 28(1 Suppl 1):4-8. PubMed ID: 11273589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of adjuvant systemic chemotherapy for colon cancer.
    Andre T; de Gramont A;
    Clin Colorectal Cancer; 2004 Jun; 4 Suppl 1():S22-8. PubMed ID: 15212702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant intraperitoneal 5-fluorouracil in high-risk colon cancer: A multicenter phase III trial.
    Vaillant JC; Nordlinger B; Deuffic S; Arnaud JP; Pelissier E; Favre JP; Jaeck D; Fourtanier G; Grandjean JP; Marre P; Letoublon C
    Ann Surg; 2000 Apr; 231(4):449-56. PubMed ID: 10749603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.